Brief: SELLAS Life Sciences FY Net Income USD -26.863 Million
19/03/2026 20:05
Mar 19 (Reuters) - SELLAS Life Sciences FY basic EPS USD -0.25. FY operating income USD -28.274 million FY operating expenses USD 28.274 million
Recent news on Sellas Life Sciences
See all newsBrief: Sellas Life Sciences Reaches 80Th Event In Phase 3 Regal Trial Of Galinpepimut-S (Gps) In Acute Myeloid Leukemia
SELLAS Life Sciences Q2 net loss widens on higher expenses
Brief: SELLAS Life Sciences Q2 Net Income USD -9.605 Million
Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SELLAS Life Sciences Q1 net loss widens on higher expenses